These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24251808)

  • 1. New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
    Palmer AM
    Br J Clin Pharmacol; 2014 Jul; 78(1):33-43. PubMed ID: 24251808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying agents in multiple sclerosis.
    O'Connor PW; Oh J
    Handb Clin Neurol; 2014; 122():465-501. PubMed ID: 24507532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
    Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis.
    English C; Aloi JJ
    Clin Ther; 2015 Apr; 37(4):691-715. PubMed ID: 25846320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs in development for relapsing multiple sclerosis.
    Ali R; Nicholas RS; Muraro PA
    Drugs; 2013 May; 73(7):625-50. PubMed ID: 23609782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Emerging therapies for multiple sclerosis].
    de Lorenzo-Pinto A; Rodríguez-González CG; Ais-Larisgoitia A
    Med Clin (Barc); 2013 Jan; 140(2):76-82. PubMed ID: 22766059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Aspects of Approved MS Therapeutics.
    Rommer PS; Milo R; Han MH; Satyanarayan S; Sellner J; Hauer L; Illes Z; Warnke C; Laurent S; Weber MS; Zhang Y; Stuve O
    Front Immunol; 2019; 10():1564. PubMed ID: 31354720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multiple sclerosis - success from bench to bedside.
    Tintore M; Vidal-Jordana A; Sastre-Garriga J
    Nat Rev Neurol; 2019 Jan; 15(1):53-58. PubMed ID: 30315270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Agents for Relapsing Forms of Multiple Sclerosis.
    Straus Farber R; Harel A; Lublin F
    Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs.
    Lebrun C; Rocher F
    CNS Drugs; 2018 Oct; 32(10):939-949. PubMed ID: 30143945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological treatment of multiple sclerosis.
    Diebold M; Derfuss T
    Semin Hematol; 2016 Apr; 53 Suppl 1():S54-7. PubMed ID: 27312167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies in relapsing-remitting multiple sclerosis.
    Marriott JJ; O'Connor PW
    Rev Recent Clin Trials; 2010 Sep; 5(3):179-88. PubMed ID: 20500147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM; Rainka MM; Patel MJ; Gengo FM
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapies targeting the immune system in multiple sclerosis.
    Loleit V; Biberacher V; Hemmer B
    Curr Pharm Biotechnol; 2014; 15(3):276-96. PubMed ID: 24938888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New biological agents in the treatment of multiple sclerosis.
    Buc M
    Bratisl Lek Listy; 2018; 119(4):191-197. PubMed ID: 29663814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer agents in the treatment of multiple sclerosis.
    Pawate S; Bagnato F
    Neurologist; 2015 Apr; 19(4):104-17. PubMed ID: 25888198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.